This announcement is a separate document:
万联证券股份有限公司关于宁波美诺华药业股份有限公司IPO节余募集资金永久补充流动资金的核查意见
Wanlian Securities Co., Ltd.'s verification opinion on the permanent supplement of the remaining IPO funds of Ningbo Menovo Pharmaceutical Co., Ltd. for the permanent supplement of working capital.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.